Bcl-2 inhibitor HA14-1, Purity ≥98%

Cat. No.: X23-10-ZQ005

Bcl-2 inhibitor HA14-1, Purity ≥98%

Synonym: 65673-63-4; Ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate; Bcl-2 inhibitor

  • MDL: MFCD00218213
  • CAS Number: 65673-63-4
  • Compound CID: 3549
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
HA14-1, soluble in DMSO and ethanol and insoluble in water, specifically inhibits the function of the anti-apoptotic proteins, thereby promoting apoptosis in cancer cells. It targets Bcl-2.
Molecular Weight
409.2
Molecular Formula
C17H17BrN2O5
Targets
Bcl-2: 9 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 80 mg/mL (195.48 mM); Water: Insoluble; Ethanol: 80 mg/mL (195.48 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
HA14-1 induces apoptosis in cancer cells by interfering with BCL-2’s anti-apoptotic function.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0